UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia

The New England journal of medicine, 2009-11, Vol.361 (19), p.1848-1855

2009

Volltextzugriff (PDF)

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

Blood, 2006-09, Vol.108 (6), p.1830-1834

2006

Volltextzugriff (PDF)

Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model

Experimental hematology, 2007-08, Vol.35 (8), p.1201-1208

2007

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers

Journal of clinical pharmacology, 2008-01, Vol.48 (1), p.43-52

2008

Volltextzugriff (PDF)

Hematopoietic Recovery Following Autologous Bone Marrow Transplantation in a Nonhuman Primate: Effect of Variation in Treatment Schedule with PEG‐rHuMGDF

Stem cells (Dayton, Ohio), 2003-01, Vol.21 (1), p.79-89

2003

Volltextzugriff (PDF)

Abstract CT002: A strong HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer is associated with prolonged survival

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT002-CT002

2019

Volltextzugriff (PDF)

Correlation between strength of T-cell response against HPV16 and survival after vaccination with HPV16 long peptides in combination with chemotherapy for late-stage cervical cancer

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.140-140

2017

Volltextzugriff (PDF)

Association of T cell responses after vaccination with HPV16 long peptides for late stage cervical cancer with prolonged survival

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5525-5525

2017

Volltextzugriff (PDF)

Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis

The New England journal of medicine, 1990-02, Vol.322 (5), p.315-317

1990

Volltextzugriff (PDF)

Dose-Response Effects of Pegylated Human Megakaryocyte Growth and Development Factor on Platelet Production and Function in Nonhuman Primates

Blood, 1996-07, Vol.88 (2), p.511-521

1996

Volltextzugriff (PDF)

Preclinical studies and potential clinical applications of c-mpl ligand

Current opinion in hematology, 1996, Vol.3 (3), p.197-202

1996

Volltextzugriff (PDF)

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor

Blood, 1997, Vol.89 (1), p.155-165

1997

Volltextzugriff (PDF)

Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates

Blood, 1996-03, Vol.87 (5), p.1833-1844

1996

Volltextzugriff (PDF)

Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy

Blood, 2007-11, Vol.110 (11), p.3666-3666

2007

Volltextzugriff (PDF)

Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor

Blood, 1998-06, Vol.91 (12), p.4427-4433

1998

Volltextzugriff (PDF)

Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor

Blood, 1997-01, Vol.89 (1), p.155-165

1997

Volltextzugriff (PDF)

Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor

Blood, 1998-06, Vol.91 (12), p.4427-4433

1998

Volltextzugriff (PDF)

Canine Model for Gene Therapy: Inefficient Gene Expression in Dogs Reconstituted With Autologous Marrow Infected With Retroviral Vectors

Blood, 1988-03, Vol.71 (3), p.742-747

1988

Volltextzugriff (PDF)

Erythropoietin and Visual Hallucinations

The New England journal of medicine, 1991-07, Vol.325 (4), p.285-285

Steinberg, H

1991

Volltextzugriff (PDF)

Improved Retroviral Transfer of Genes Into Canine Hematopoietic Progenitor Cells Kept in Long-Term Marrow Culture

Blood, 1989-07, Vol.74 (1), p.152-155

1989

Volltextzugriff (PDF)

Regulation of Platelet Production and Function by Megakaryocyte Growth and Development Factor in Nonhuman Primates

Blood, 1996-03, Vol.87 (5), p.1833-1844

1996

Volltextzugriff (PDF)

Retroviral Transfer of Genes into Canine Hemopoietic Progenitor Cells in Culture: A Model for Human Gene Therapy

Proceedings of the National Academy of Sciences - PNAS, 1986-06, Vol.83 (12), p.4552-4555

1986

Volltextzugriff (PDF)

Medical Intelligence: Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis

The New England journal of medicine, 1990-02, Vol.322 (5), p.315

1990

Volltextzugriff (PDF)

Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism

The American journal of medicine, 1984-07, Vol.77 (1), p.185-188

1984

Volltextzugriff (PDF)

Retroviral transfer of genes into canine hematopoietic progenitor cells

Advances in experimental medicine and biology, 1988, Vol.241, p.9

1988

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model

Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers

Hematopoietic Recovery Following Autologous Bone Marrow Transplantation in a Nonhuman Primate: Effect of Variation in Treatment Schedule with PEG‐rHuMGDF

Abstract CT002: A strong HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer is associated with prolonged survival

Correlation between strength of T-cell response against HPV16 and survival after vaccination with HPV16 long peptides in combination with chemotherapy for late-stage cervical cancer

Association of T cell responses after vaccination with HPV16 long peptides for late stage cervical cancer with prolonged survival

Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis

Dose-Response Effects of Pegylated Human Megakaryocyte Growth and Development Factor on Platelet Production and Function in Nonhuman Primates

Preclinical studies and potential clinical applications of c-mpl ligand

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor

Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates

Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy

Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor

Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor

Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor

Canine Model for Gene Therapy: Inefficient Gene Expression in Dogs Reconstituted With Autologous Marrow Infected With Retroviral Vectors

Erythropoietin and Visual Hallucinations

Improved Retroviral Transfer of Genes Into Canine Hematopoietic Progenitor Cells Kept in Long-Term Marrow Culture

Regulation of Platelet Production and Function by Megakaryocyte Growth and Development Factor in Nonhuman Primates

Retroviral Transfer of Genes into Canine Hemopoietic Progenitor Cells in Culture: A Model for Human Gene Therapy

Medical Intelligence: Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis

Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism

Retroviral transfer of genes into canine hematopoietic progenitor cells

Suchergebnisse filtern